Retinal & Fundus Images
Buy and sell retinal & fundus images data. Eye fundus photos detect diabetic retinopathy, glaucoma, and even cardiovascular risk. Ophthalmic AI needs diverse retinal datasets.
No listings currently in the marketplace for Retinal & Fundus Images.
Find Me This Data →Overview
What Is Retinal & Fundus Images Data?
Retinal and fundus images are high-resolution photographs of the back of the eye (fundus) used to detect and monitor diseases like diabetic retinopathy, glaucoma, and age-related macular degeneration. These images are captured using fundus cameras—both mydriatic (requiring pupil dilation) and non-mydriatic (dilation-free) models—and serve as critical diagnostic tools in ophthalmology and optometry. The global fundus camera market alone reached USD 654.08 million in 2025 and is projected to grow significantly as healthcare providers increasingly adopt these technologies for disease screening and early detection. Retinal imaging datasets are particularly valuable for artificial intelligence and machine learning applications in ophthalmic diagnostics. Researchers and medical device companies require diverse, annotated retinal datasets to train algorithms that can automatically detect pathological conditions with high sensitivity and specificity. The broader retinal imaging devices market—encompassing fundus cameras, optical coherence tomography (OCT), and related technologies—was valued at USD 3.74 billion in 2023 and is expanding as diabetes prevalence rises globally and healthcare infrastructure improves.
Market Data
USD 654.08 million
Fundus Camera Market Size (2025)
Source: Fortune Business Insights
USD 1,116.81 million
Projected Fundus Camera Market (2034)
Source: Fortune Business Insights
USD 3.74 billion
Retinal Imaging Devices Market (2023)
Source: Grand View Research
USD 6.35 billion
Projected Retinal Imaging Devices Market (2030)
Source: Grand View Research
36.40%
North America Market Share (2025)
Source: Fortune Business Insights
Who Uses This Data
What AI models do with it.do with it.
Diabetic Retinopathy Screening
Retinal images are essential for detecting and staging diabetic retinopathy, a leading cause of vision loss. Non-mydriatic fundus cameras enable rapid, patient-friendly screening in primary care, diabetes clinics, and community health programs without requiring pupil dilation.
Ophthalmology & Optometry Practices
Hospitals, ophthalmic clinics, and optometrist offices rely on fundus images for routine eye disease diagnosis, including glaucoma, age-related macular degeneration (AMD), and cardiovascular risk assessment through retinal vascular changes.
AI & Machine Learning Development
Medical device companies and AI researchers require large, diverse, and annotated retinal datasets to train diagnostic algorithms. High-quality fundus images with clinical annotations enable development of FDA-cleared AI tools for automated disease detection.
Clinical Research & Population Health
Public health agencies and researchers use retinal imaging datasets for epidemiological studies, screening program validation, and longitudinal tracking of retinal disease progression in diverse populations.
What Can You Earn?
What it's worth.worth.
Individual Fundus Images (Unlabeled)
Varies
Pricing depends on image quality, resolution, and use rights. Buyer demand increases for diverse demographic representation and diverse retinal pathology coverage.
Annotated Retinal Datasets
Varies
Clinical annotation, disease severity grading, and diagnostic labels significantly increase value. AI/ML companies pay premiums for datasets with validated ground truth.
Longitudinal Patient Data
Varies
Sequential retinal images from the same patient showing disease progression are highly valued for algorithm training and clinical validation studies.
Diverse Population Cohorts
Varies
Datasets representing underrepresented demographics and different ethnic/genetic backgrounds command higher prices due to industry need for algorithmic equity.
What Buyers Expect
What makes it valuable.valuable.
Image Resolution & Clarity
High-resolution fundus photographs with clear visualization of optic disc, macula, and peripheral retina. Images must meet clinical diagnostic standards comparable to professional fundus cameras used in clinical practice.
Clinical Annotation & Labeling
Accurate disease classification (diabetic retinopathy severity, glaucoma presence, AMD stage, etc.) by qualified ophthalmologists or certified graders. AI/ML buyers require pixel-level or region-level annotations for model training.
Demographic & Metadata Documentation
Complete patient metadata including age, gender, ethnicity, relevant medical history (diabetes status, hypertension, etc.), and imaging parameters (camera type, mydriasis status, eye laterality).
Regulatory & Privacy Compliance
Full HIPAA compliance with verified de-identification, informed consent documentation, and institutional review board (IRB) approval. FDA-regulated medical device companies require validated data provenance and quality assurance.
Diverse Disease Representation
Balanced representation of normal retinas, early-stage disease, and advanced pathology. AI developers need datasets covering the full spectrum of diagnostic categories to train robust, generalizable algorithms.
Companies Active Here
Who's buying.buying.
Medical device manufacturers dominating the fundus camera market. These companies acquire retinal datasets for algorithm development, device validation, and clinical evidence generation for regulatory submissions.
Developer of the FDA-cleared Optomed Aurora AEYE, the first handheld AI fundus camera for diabetic retinopathy detection (92%-93% diagnostic sensitivity). Requires diverse training datasets for AI validation and geographic expansion.
Large hospital and clinic chains implementing retinal screening programs for diabetes and chronic disease management. Buyers of both equipment and supporting image analysis services.
Universities and research hospitals conducting retinal imaging research, algorithm development, and clinical validation studies. Active acquirers of annotated datasets for peer-reviewed research.
FAQ
Common questions.questions.
What retinal diseases can fundus images detect?
Fundus images can detect diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), and provide indicators of broader cardiovascular health. Recent FDA-cleared AI systems achieve 92%-93% diagnostic sensitivity for diabetic retinopathy detection.
Why do AI/ML companies need diverse retinal datasets?
Ophthalmic AI algorithms require large, diverse datasets representing multiple demographic groups, disease stages, and imaging conditions to achieve diagnostic accuracy, prevent algorithmic bias, and gain regulatory approval for clinical deployment.
What's the difference between mydriatic and non-mydriatic fundus cameras?
Non-mydriatic cameras capture retinal images without requiring pupil dilation, making them more patient-friendly for screening in primary care. They represent the largest market segment due to ease of use in diabetic retinopathy screening programs.
How large is the market for retinal imaging equipment and data?
The global fundus camera market alone was USD 654.08 million in 2025, projected to reach USD 1.1+ billion by 2034. The broader retinal imaging devices market (including OCT and other modalities) reached USD 3.74 billion in 2023 and is expected to grow to USD 6.35 billion by 2030.
Sell yourretinal & fundus imagesdata.
If your company generates retinal & fundus images, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation